Search results
With iOnctura and Yellowstone, Syncona adds two cancer biotechs to growing portfolio
FierceBiotech· 3 days agoSyncona has added two up-and-coming cancer companies to its portfolio, ensuring the biotechs are armed with a combined total of over $100 million in series A and B funds.
Angle Raises $630K in Open Offer of Shares
GenomeWeb News· 2 days agoCirculating tumor cell tech firm Angle said Friday that pursuant to its open offer announced on June 5, it has raised gross proceeds of £500,000 ($631,658), which will be ...
Lifestyle changes may slow or improve Alzheimer’s and dementia, study finds | CNN
CNN.com· 5 days agoLooking back, Tammy Maida, 67, said things started to change in her late 50s. A lifelong, avid...
Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs
BioPharma Dive via Yahoo Finance· 2 days agoA medicine Jazz acquired in 2019 missed the goal of a Phase 2 study. Elsewhere, Vanda rejected two...
Newswise Expert | Shilpa Gupta, Case Western Reserve University
Newswise· 7 days agoDr. Gupt
Council Post: How Multi-Omics Is Empowering The Discovery Of Cancer Biomarkers
Forbes· 5 days agoDemaris Mills is president at Integrated DNA Technologies, a global genomics solutions provider....
Meet the man who combines science, technology and magic to understand proteins - Marketplace
Marketplace· 4 days agoMarketplace’s Lily Jamali recently visited the company’s headquarters to meet with Parag Mallick,...
Cedarville University professor continuing cancer treatment research with students’ help
Dayton Daily News· 2 days agoA local professor, who orginally hails from Abuja, Nigeria, is continuing his research on the...
Ceftazidime is a potential drug to inhibit cell proliferation by increasing cellular p27 - The...
Nature· 4 days agoHere, we found that the antimicrobial drug ceftazidime strongly upregulates p27 protein levels by inhibiting p27 ubiquitination. The p27 protein is a classic negative regulator of the
IgG4-Related Disease Affects Men More Often, More Severely
Medscape· 3 days agoA recent study highlighted sex-based differences in manifestations of IgG4-related disease.
